Ledger.Open graph →
SEC Form D · filed May 22, 2023

Convergent Therapeutics, Inc

Offering
$99.2M
Sold
$29.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Jake Simson · Cambridge, MADirectorAlexander Brown · Cambridge, MAExecNeil Bander · Cambridge, MADirectorTal Zaks · Cambridge, MADirectorPhilip Kantoff · Cambridge, MAExec · DirectorVincent Palmieri · Larchmont, NYDirectorJonathan Hua Jun Xiong · SINGAPORE, U0ExecNeil Mackie · EDINBURGH, United KingdomExec · DirectorStacey-Ann Kirkconnell · GEORGE TOWN, GRAND CAYMAN, Cayman IslandsDirectorDan K. Thomason · Greenville, SCDirectorBrooke T. Lambert · New York, NYDirectorAvi Cohen · Lod, L3DirectorChristine Y. Zhao · Lod, L3Exec · DirectorTodd Thomson · Lod, L3ExecFang Zheng · Lod, L3Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗